Skip to Main Content

Paper Details

EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling.
Mol Cell
136
2015
BET-bromodomain, EGFR, EGFR mutation, EGFRvIII, Epidermal growth factor receptor, Epidermal growth factor receptor (EGFR) gene, Epigenome, FOXG1, GBM, GBM cells, Glioblastoma, JQ1, SOX9, activated enhancer landscape, cell lines, clinical samples, epigenome, glioblastoma, tumor
Author NameAffiliation
Gary C HonLudwig Institute for Cancer Research
Gary C HonLudwig Institute for Cancer Research
Zhen YeLudwig Institute for Cancer Research
Zhen YeLudwig Institute for Cancer Research
Bin LiLudwig Institute for Cancer Research
Samantha KuanLudwig Institute for Cancer Research
Samantha KuanLudwig Institute for Cancer Research
Ah Young LeeLudwig Institute for Cancer Research
Frank B FurnariLudwig Institute for Cancer Research, university of california san diego School of Medicine
Timothy F CloughesyDavid Geffen university of california los angeles School of Medicine
Timothy F CloughesyDavid Geffen university of california los angeles School of Medicine
Andrew K ShiauLudwig Institute for Cancer Research
Webster K CaveneeLudwig Institute for Cancer Research, university of california san diego School of Medicine, USA Moores Cancer Center
Bing RenLudwig Institute for Cancer Research, Institute of Genomic Medicine, university of california san diego School of Medicine, USA Moores Cancer Center
Bing RenLudwig Institute for Cancer Research, Institute of Genomic Medicine, university of california san diego School of Medicine, USA Moores Cancer Center
Paul S MischelLudwig Institute for Cancer Research, university of california san diego School of Medicine, USA Moores Cancer Center
  • 1 - 16

Datasets

Release 1.2